IRLAB to present at Redeye Theme: Neurology
GOTHENBURG, SE / ACCESS Newswire / October 9, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that CEO Kristina Torfgård will present IRLAB at …
Weiterlesen »